People have successfully made it as far away from Earth as possible. Is this because of how bad things have gotten here, Brett, or is this an achievement uh that we should be celebrating? No, I'll I'll reframe this. That's great. We've got SpaceX secretly filing for an IPO. At the same time, you've got Artemis and NASA's program that is achieving something incredible, but at a enormous cost. Uh how do you think about these two dynamics playing out uh with the private and public space now intertwining more t ...

Financial Data and Key Metrics Changes - In Q4 2025, revenue was $33.4 million, down approximately 15% year-over-year, with same-store revenue declining 16% [14] - For the full year 2025, total revenue was $151.8 million, a decrease of approximately 15.8% compared to fiscal 2024 [15] - Adjusted EBITDA for Q4 was $2.5 million, representing a margin of 7.4%, an increase of $0.6 million and 2.8% margin expansion year-over-year [15] - Full year adjusted EBITDA was approximately $15 million, resulting in an adjusted EBITDA margin of approximately 10% [15] Business Line Data and Key Metrics Changes - The company reported improvements in lead and consult volumes, which have continued into 2026, contributing to improved revenue trends [5] - Over 100 skin removal surgeries were completed in Q4 2025, with expectations for ramp-up in 2026 as capabilities expand across all locations [8] Market Data and Key Metrics Changes - The skin tightening and skin removal market is projected to be as large as fat removal, representing a long-term sales opportunity exceeding $100 million [7] - The percentage of patients using financing for procedures was approximately 50% [14] Company Strategy and Development Direction - The company is focused on introducing new services to capture the GLP-1 market opportunity, enhancing sales and marketing strategies, and maintaining strong financial discipline [6] - Strategic exit from the only clinic outside North America was made to streamline operations [5] - The company aims to build on momentum and drive disciplined growth to create shareholder value [10] Management's Comments on Operating Environment and Future Outlook - Management noted that 2025 was a year of rebuilding and transformation, with same-store sales improving from down 22% at the start of 2025 to positive in February 2026 [5] - The company expects revenue in 2026 to range from $151 million to $157 million, reflecting approximately 3% comparable growth [17] - Management expressed confidence in the full-year outlook, citing improved trends and a focus on execution [22] Other Important Information - The company paid down $19 million of debt in 2025, with gross debt outstanding at $56 million at year-end [16] - A reconciliation matter related to intercompany transactions was identified, leading to immaterial changes in prior year balances, but had no impact on revenue or cash [13] Q&A Session Summary Question: Guidance for 1Q indicates a slight decline year-over-year, while full year 2026 revenue is expected to be up slightly. What is causing this change in seasonality? - Management acknowledged improved trends and emphasized the need for consistent results to meet guidance [22] Question: Can you provide insights on body sculpting trends outside of GLP-1 related procedures? - Management noted that the core business around body contouring and fat removal is holding steady, with GLP-1s expected to drive future demand [23] Question: What feedback have you received from customers and surgeons regarding excisional procedures? - Management reported positive early results from patients and comfort among surgeons, with plans to ramp up procedures throughout the year [27] Question: How should capital allocation be viewed going forward regarding debt pay down versus investments? - Management indicated that the priority remains on maintaining a healthy balance sheet while also investing back into the business for growth initiatives [29]

Financial Data and Key Metrics Changes - In Q4 2025, revenue was $33.4 million, down approximately 15% year-over-year, with same-store revenue declining 16% [14] - For the full year 2025, total revenue was $151.8 million, a decrease of approximately 15.8% compared to fiscal 2024 [15] - Adjusted EBITDA for Q4 was $2.5 million, representing a margin of 7.4%, an increase of $0.6 million and 2.8% margin expansion year-over-year [15] - Full year adjusted EBITDA was approximately $15 million, resulting in an adjusted EBITDA margin of approximately 10% [15] Business Line Data and Key Metrics Changes - The company reported improvements in lead and consult volumes, contributing to better revenue trends moving into 2026 [5] - Over 100 skin removal surgeries were completed in Q4 2025, with expectations for ramp-up in 2026 as capabilities expand across all locations [8] Market Data and Key Metrics Changes - The skin tightening and skin removal market is projected to be as large as fat removal, representing a long-term sales opportunity exceeding $100 million [7] - The percentage of patients using financing for procedures was approximately 50% [14] Company Strategy and Development Direction - The company is focusing on introducing new services to capture the GLP-1 market opportunity, enhancing sales and marketing strategies, and maintaining strong financial discipline [6] - Strategic exit from the only clinic outside North America was made to streamline operations [5] - The company aims to build on momentum and drive disciplined growth to create shareholder value [10] Management's Comments on Operating Environment and Future Outlook - Management noted that 2025 was a year of rebuilding and transformation, with same-store sales improving from down 22% at the start of 2025 to positive in February 2026 [5] - The company expects revenue in 2026 to range from $151 million to $157 million, reflecting approximately 3% comparable growth [17] - Management acknowledged the need to monitor the helium plasma supply situation due to geopolitical issues affecting skin tightening procedures [18] Other Important Information - The company paid down $19 million of debt in 2025, with gross debt outstanding at $56 million at year-end [16] - Cash flow from operations for the year was $3.1 million, down from $11.4 million in fiscal 2024 [17] Q&A Session Summary Question: Guidance for 1Q indicates a slight decline year-over-year, while full year 2026 revenue is expected to be up slightly. What is causing this change in seasonality? - Management indicated that trends have improved significantly, and they are focused on execution to ensure they meet their numbers [22] Question: Can the company isolate market trends for the core business outside of GLP-1 related procedures? - Management noted that the core business around body contouring and fat removal is holding steady, with GLP-1 being the next wave of change [23] Question: What feedback has the company received regarding excisional procedures from the pilot phase? - Management reported excellent results from patients and comfort from surgeons, with plans to ramp up procedures as the year progresses [27] Question: How should capital allocation be viewed going forward regarding debt pay down versus business investment? - Management emphasized the priority of maintaining a healthy balance sheet while also investing back into the business for growth initiatives [29]

Group 1 - The article does not provide any relevant content regarding company or industry insights [1]

Core Insights - Milestone Scientific Inc. is transitioning from a restructuring phase to a growth phase, with expectations for double-digit revenue growth in 2026 and a significant increase in CompuFlo sales [2][3]. Business Update - The company has implemented financial discipline since August 2025, focusing on revenue-generating initiatives and eliminating inefficient spending [2]. - A dental ambassador program was launched in December 2025, and CompuFlo commercialization efforts are being relaunched [2]. - The company is processing registrations for its STA product in Japan, India, and Mexico, while also securing new distribution partners for CompuFlo [2]. Financial Performance - For Q4 2025, total revenue was $2.1 million, a 2.2% increase from $2.0 million in Q4 2024 [4]. - The operating loss for Q4 2025 improved by 89% to $1.1 million compared to $2.0 million in the prior year [5]. - For the full year 2025, total revenue was $9.0 million, a 4% increase from $8.6 million in 2024, driven by higher international dental sales [6][7]. Future Outlook - For 2026, total revenue is expected to be between $9.8 million and $10.2 million, with CompuFlo revenue projected to increase by approximately 400% to between $500,000 and $600,000 [9]. - The company aims to achieve cash flow breakeven by early 2027, focusing on long-term shareholder value [3].

Core Insights - Jones Soda Co. reported a significant increase in revenue for Q4 2025, with a 450% rise to $11.7 million and a positive adjusted EBITDA of $0.5 million [1][3] - For the full year 2025, revenue increased by 42% to $25.3 million, with an adjusted EBITDA improvement of $5.2 million year-over-year [1][5] Financial Performance - Revenue from continuing operations rose by 42% to $25.3 million compared to $17.8 million in 2024, driven by new core soda sales and increased direct-to-consumer sales [3][5] - Adjusted gross profit margin from continuing operations increased to 32%, up from 27% in the previous year [3][6] - The net loss from continuing operations was reduced by 82% to $1.8 million, or $(0.01) per share, compared to a net loss of $9.9 million, or $(0.09) per share in 2024 [3][8] - Total operating expenses from continuing operations were $4.1 million, up from $3.2 million, primarily due to license and broker fees related to revenue growth [3][6] Business Highlights - The company launched new products, including Supply Pack and Rocket Bottle, in partnership with a leading gaming franchise [3][4] - Expanded distribution with a major warehouse club operator, significantly increasing product availability across Canada [3][4] - The company anticipates Q1 2026 revenue to exceed $12 million, representing a 260% increase year-over-year, and expects FY2026 revenue to exceed $40 million, up over 60% [2][11] Operational Improvements - The CEO highlighted that 2025 was a transformational year, marked by strong growth, expanded distribution, and operational improvements [4] - The company focused on streamlining operations, optimizing the supply chain, and implementing cost management strategies [4] Cash Position - As of December 31, 2025, the company had cash and cash equivalents of $3.6 million, up from $1.3 million at the end of 2024 [9]

Core Insights - Stran & Company, Inc. (SWAG) has shown relative resilience in its stock performance, declining 2.3% since its fiscal 2025 earnings report, compared to a 3% decline in the S&P 500 index [1] - The company reported a significant revenue increase of 40.6% year over year, reaching $116.2 million, while net loss narrowed to $0.7 million from $4.1 million in the previous year [2] - The company is transitioning towards profitability, supported by strong growth momentum, acquisitions, and deeper customer engagement [13] Financial Performance - Total revenues for fiscal 2025 rose to $116.2 million from $82.7 million in 2024, marking a 40.6% increase [2] - Gross profit increased by 32.6% to $34.2 million, although gross margin decreased to 29.5% from 31.2% [2] - Operating expenses rose 17.8% year over year to $36.2 million, but as a percentage of revenue, they declined to 31.1% from 37.2%, indicating improved operating leverage [5] Segment Performance - The core Stran segment generated $82.1 million in sales, up 12.9% year over year, driven by increased spending from existing customers and new client acquisitions [3] - The SLS segment, including the acquired Gander Group, saw sales surge 242.6% year over year to $34.1 million due to a full year of consolidated operations [3] - The company served over 2,000 active customers, including more than 30 Fortune 500 companies, highlighting a diversified client base [4] Strategic Initiatives - Management characterized 2025 as a "defining year," focusing on scalability and strengthening long-term customer relationships [6] - The launch of a client-branded online gifting platform expanded e-commerce capabilities and created an additional recurring revenue stream [7] - Continued investment in technology and leadership additions were noted as steps to support future growth [7] Challenges and Outlook - Revenue growth was influenced by higher client spending, new customer acquisition, and the integration of Gander Group assets, but margins were pressured by the lower-margin profile of the acquired business [8] - Elevated legal and accounting expenses impacted profitability, but improved scale and operating efficiencies helped offset cost pressures [9] - The company expects improved profitability in the first quarter, supported by continued customer demand and strategic initiatives [10]

Revenue Growth: Phreesia's total revenue for Q4 reached $127.1 million, a 16% year-over-year increase, surpassing estimates.Operational Efficiency: The company achieved a positive GAAP net income of $2.3 million and generated $50 million in free cash flow.Financial Stability: With a quick and current ratio of 2.44 and a debt-to-equity ratio of 0.01, Phreesia maintains strong liquidity and low leverage.(NYSE:PHR) is a healthcare technology company that provides patient intake management solutions. It helps h ...

Core Insights - SEGG Media has appointed Daniel Bailey as Chief Commercial Officer and Jack Clarke as Chief Strategy Officer to enhance its leadership team during a strategic growth phase following the acquisition of Veloce [1][2] Leadership Appointments - Daniel Bailey brings over a decade of experience in motorsport and global sports commercial strategy, having generated over $53 million in commercial partnerships and revenue [3][4] - Jack Clarke, a former professional racing driver, co-founded Veloce Media Group and has been instrumental in scaling its esports operations and media network, achieving over 600 million monthly views [6][7] Strategic Focus - The company is implementing a 90-day plan aimed at execution, integration of operations, and monetization of new assets [2] - SEGG Media's strategy includes maximizing the potential of high-growth digital and media assets, accelerating monetization for platforms like Sports.com, Concerts.com, and TicketStub.com, and improving financial visibility [11] Revenue Generation - The company is positioned for near-term revenue expansion through disciplined strategy and high-impact execution [9] - Key initiatives include unlocking operating efficiencies through integration and scale, minimizing shareholder dilution, and achieving clear, measurable results to create shareholder value [11]

Core Insights - Sterling Infrastructure, Inc. (STRL) demonstrates strong backlog growth but faces challenges in its Building Solutions segment due to housing market weaknesses [1][3] Backlog and Growth Potential - The company ended 2025 with a record backlog of $3.01 billion, representing a 78% year-over-year increase, driven by strong demand in E-Infrastructure and Transportation segments [2][9] - With an additional $300 million in unsigned awards and future opportunities exceeding $1 billion, STRL has a total pipeline visibility of $4.5 billion, supporting sustained revenue growth and management's confidence in achieving over 25% growth in key financial metrics for 2026 [2] Segment Performance - The E-Infrastructure segment remains the primary growth driver, experiencing triple-digit revenue growth in Q4 due to demand for data centers and semiconductor facilities, bolstered by strategic expansion and the CEC acquisition [3] - The Transportation segment shows resilience with a favorable project mix and steady bidding activity [3] - Conversely, the Building Solutions segment is experiencing revenue and operating profit declines due to affordability issues and softness in the residential housing market, with further declines expected in 2026 [3][9] Strategic Positioning - Sterling's strategic shift towards higher-margin, mission-critical infrastructure is yielding positive results, with strong backlog conversion and margin expansion helping to mitigate cyclical housing pressures [4] - The company operates with a differentiated execution-led model compared to competitors AECOM and Fluor Corp., focusing on niche high-growth markets [5][7] Stock Performance and Valuation - STRL shares have increased by 37.3% over the past three months, outperforming the Zacks Engineering - R and D Services industry, the broader Construction sector, and the S&P 500 Index [8] - The stock is currently trading at a premium with a forward 12-month price-to-earnings (P/E) ratio of 29.61 [11] Earnings Estimates - Earnings estimates for STRL for 2026 and 2027 have been revised upward, indicating expected year-over-year growth of 25.8% and 15%, respectively [12]